Microneedle aptamer-based sensors for continuous, real-time therapeutic drug monitoring

Y Wu, F Tehrani, H Teymourian, J Mack… - Analytical …, 2022 - ACS Publications
The ability to continuously monitor the concentration of specific molecules in the body is a
long-sought goal of biomedical research. For this purpose, interstitial fluid (ISF) was …

Pharmacokinetics and pharmacodynamics of peptide antibiotics

X Bian, X Qu, J Zhang, SC Nang, PJ Bergen… - Advanced drug delivery …, 2022 - Elsevier
Antimicrobial resistance is a major global health challenge. As few new efficacious
antibiotics will become available in the near future, peptide antibiotics continue to be major …

AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics

SCJ Jorgensen, D Dersch-Mills… - Journal of …, 2021 - academic.oup.com
The revised vancomycin guidelines recommend implementing AUC24-based therapeutic
drug monitoring (TDM) using Bayesian methods in both adults and paediatrics. The …

Optimization of vancomycin aptamer sequence length increases the sensitivity of electrochemical, aptamer-based sensors in vivo

A Shaver, JD Mahlum, K Scida, ML Johnston… - ACS …, 2022 - ACS Publications
The measurement of serum vancomycin levels at the clinic is critical to optimizing dosing
given the narrow therapeutic window of this antibiotic. Current approaches to quantitate …

An area under the concentration–time curve threshold as a predictor of efficacy and nephrotoxicity for individualizing polymyxin B dosing in patients with carbapenem …

J Yang, S Liu, J Lu, T Sun, P Wang, X Zhang - Critical Care, 2022 - Springer
Background Evidence supports therapeutic drug monitoring of polymyxin B, but clinical data
for establishing an area under the concentration–time curve across 24 h at steady state …

Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant Staphylococcus aureus Endovascular Infections?

W Rose, C Volk, TJ Dilworth… - Open Forum Infectious …, 2022 - academic.oup.com
Vancomycin was introduced nearly 65 years ago and remains the standard antibiotic for
serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Staphylococcus …

Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant …

SCJ Jorgensen, B Spellberg, AF Shorr… - Clinical Infectious …, 2021 - academic.oup.com
In this counterpoint we critically appraise the evidence supporting therapeutic drug
monitoring based on the vancomycin 24-hour area under the concentration-time curve …

[HTML][HTML] How I manage a patient with MRSA bacteraemia

JS Davis, N Petersiel, SYC Tong - Clinical Microbiology and Infection, 2022 - Elsevier
Background Staphylococcus aureus bloodstream infections are common and associated
with a high mortality of 15–25%. Methicillin-resistant S. aureus (MRSA) bloodstream …

Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapy

JD Frazier, LL Stoudenmire, JL Wagner… - International Journal of …, 2023 - Elsevier
Background This study compared dalbavancin with standard of care (SOC) for patients with
Staphylococcus aureus bacteraemia (SAB) who were unable to receive outpatient …

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: pharmacokinetic model and model‐informed precision dosing trial simulations

A Aljutayli, DJG Thirion, G Bonnefois… - Clinical and …, 2022 - Wiley Online Library
The recently released revised vancomycin consensus guideline endorsed area under the
concentration‐time curve (AUC) guided monitoring. Means to AUC‐guided monitoring …